
Invesco QQQ Equal Weight ETF
Invesco QQQ Equal Weight ETF (QEW) Price & Chart
QEW ETF Chart & Stats
- Day’s Range
- $28.88 - $29.25
- 52-Week Range
- $23.71 - $31.00
- Previous Close
- $28.53
- Volume
- 16.71K
- Average Volume (3M)
- 22.27K
- AUM
- 31.38M
- NAV
- 29.16
- Expense Ratio
- 0.25%
- Holdings Count
- 103
- Beta
- 1.17
- Inception Date
- Mar 18, 2026
- Last Dividend Ex-Date
- Sep 21, 2026
- Dividend Yield
- (0.29%)
- Shares Outstanding
- 1,100,001
- Standard Deviation
- N/A
ETF Overview
Invesco QQQ Equal Weight ETF
Invesco QQQ Equal Weight ETF (QEW) offers investors exposure to the NASDAQ-100 index with a distinct equal-weight approach. Instead of weighting holdings by market capitalization—where the largest mega-cap names can dominate performance—QEW assigns each constituent roughly the same portfolio weight. That design spreads risk more evenly across roughly 100 of the largest non-financial companies listed on Nasdaq, reducing concentration in a handful of mega-cap technology names and increasing the relative influence of smaller large-cap constituents. Category and focus: QEW sits in the Size & Style universe as a Large Cap, Broad-based strategy with a growth tilt. Its holdings remain drawn from the NASDAQ-100, so the ETF maintains meaningful exposure to technology, consumer discretionary, communications services and healthcare sectors—but the equal-weight methodology produces a different sector and stock-level profile than a traditional cap-weighted NASDAQ product. Why investors choose QEW: the ETF is a way to capture the innovation and growth orientation of Nasdaq’s largest companies while enhancing diversification and mitigating single-stock concentration risk. The equal-weighting typically increases exposure to mid‑sized members of the index, which can lead to stronger relative performance when smaller large-caps outpace the largest names, but it can also underperform when mega-cap leaders rally strongly. Use cases: QEW can serve as a core or satellite equity holding for investors seeking diversified large‑cap growth exposure, a complement (or hedge) to cap-weighted NASDAQ ETFs, or a tactical play for those who prefer a less concentrated take on the tech-heavy NASDAQ 100. The fund’s rebalancing to maintain equal weights means its risk/return profile and turnover differ from cap-weighted alternatives—an important consideration for portfolio construction.
- Asset Class
- Equity
- Region
- North America
- Issuer
- Invesco
- Index Tracked
- NASDAQ-100 Equally Weighted Index
- Ticker Symbol
- QEW
QEW ETF News



Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals (NASDAQ: REGN) updated its Phase 2 study, officially titled “A Randomized, Double-Blind Study of The


QEW ETF FAQ
What was QEW’s price range in the past 12 months?
What is the AUM of QEW?
Is QEW overvalued?
Does QEW pay dividends?
How many shares outstanding does QEW have?
QEW ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| MRNAModerna | 1.44% |
| APPAppLovin Corp. Class A | 1.33% |
| IDXXIdexx Laboratories | 1.30% |
| MARMarriott International | 1.29% |
| KDPKeurig Dr Pepper | 1.23% |
| WMTWalmart Inc. | 1.23% |
| NXPINXP Semiconductors | 1.23% |
| REGNRegeneron Pharmaceuticals | 1.23% |
| ISRGIntuitive Surgical | 1.22% |
| TXNTexas Instruments | 1.22% |
| Total | 12.73% |









